Results 131 to 140 of about 1,154,039 (314)
The Auger Effect in Molecular Targeting Therapy
Knowledge on the physical and biological aspects of Auger-electron emission is described and the major attempts to use such emitters in cancer therapy are discussed.
Hans Lundqvist +5 more
core +1 more source
COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos +6 more
wiley +1 more source
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen +11 more
wiley +1 more source
Chelator-facilitated removal of iron from transferrin: Relevance to combined chelation therapy
Current iron chelation therapy consists primarily of DFO (desferrioxamine), which has to be administered via intravenous infusion, together with deferiprone and deferasirox, which are orally-active chelators.
Hider, Robert C +11 more
core +1 more source
Glioma cells mainly express the endothelin receptor EDNRB, while EDNRA is restricted to a perivascular tumor subpopulation. Endothelin signaling reduces glioma cell proliferation while promoting migration and a proneural‐to‐mesenchymal transition associated with poor prognosis. This pathway activates Ca2+, K+, ERK, and STAT3 signalings and is regulated
Donovan Pineau +36 more
wiley +1 more source
Early identification of golimumab-treated patients with higher likelihood of long-term retention
BackgroundThe early identification of patients’ profiles most likely to respond to and maintain long-term therapy with a biological drug can have clinical and cost-effectiveness implications.ObjectivesTo evaluate the utility of an innovative approach for
Alicia García-Dorta +9 more
doaj +1 more source
Biological Therapy of Crohn’s Disease in Ukraine
The article assesses the state of the problem of Crohn’s disease (CD) in Ukraine and the world. There has been carried out a comparative analysis of the effectiveness of using standard, as well as biological therapy in the treatment of CD by the data of ...
A.Yu. Butova +2 more
core +1 more source
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang +12 more
wiley +1 more source
Recommendation for the Management of Spondyloarthritis Patients in Kuwait
Yaser Ali,1 Fatemah Abutiban,2 Adel Alawadhi,3 Ali AlDei,4 Ahmad Alenizi,2 Hebah Alhajeri,1 Adeeba Al-Herz,4 Waleed Alkandari,5 Ahmad Dehrab,6 Eman Hasan,3 Sawsan Hayat,1 Aqeel Ghanem,1 Khulood Saleh,5 Xenofon Baraliakos7 1Mubarak Al-Kabeer Hospital ...
Ali Y +13 more
doaj
Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann +61 more
wiley +1 more source

